The healthcare cost-effectiveness watchdog NICE has recommended Novartis's pricey eye drug Lucentis, under a special scheme that will cap the cost of treatment to the state health service. The move, which follows a draft plan agreed last December, means the National Health Service will pay for a maximum of 14 injections of Lucentis per eye, with Novartis agreeing to pay if any more are needed, the National... [read full story]
|
RELATED
|
|
|
An Oxfordshire translator said she was delighted by the decision to make a drug available to save the sight of thousands of eye patients. Nice has recommended the drug Lucentis for NHS use after performing a U-turn on...
Lifeline: Joan Armstrong, 82, has been refused funding for the drug Lucentis four times by her PCT The head of the Government's drugs rationing body has made an extraordinary apology to eye disease sufferers for lengthy...
